Related Experiment Video

Updated: Jun 27, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors

A Francesca Setiadi1, Kyla Omilusik, Muriel D David

  • 1Biomedical Research Centre, Michael Smith Laboratories, Department of Zoology, University of British Columbia, Vancouver, British Columbia, Canada.

Cancer Research
|December 3, 2008
PubMed

Insights

Histone deacetylase inhibitors (HDACi), like trichostatin A (TSA), enhance anti-tumor immunity by boosting antigen presentation and MHC class I expression. This increases cancer cell susceptibility to immune attack, offering new avenues for cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Epigenetics

Background:

  • Histone deacetylase inhibitors (HDACi) are a promising class of anticancer drugs.
  • HDACi, such as trichostatin A (TSA), are known to affect cell cycle progression.
  • A novel mechanism of HDACi action in promoting anti-tumor immune responses is investigated.

Purpose of the Study:

  • To elucidate the novel mechanism of HDAC inhibitors in enhancing anti-tumor immunity.
  • To investigate the effect of TSA on antigen processing machinery and MHC class I expression in carcinoma cells.
  • To determine the role of tumor cell immunogenicity in the in vivo anti-tumoral effects of TSA.

Main Methods:

  • Treatment of carcinoma cells with TSA.
  • Analysis of antigen processing machinery components (TAP-1, TAP-2, LMP-2, Tapasin) expression.
  • Assessment of MHC class I expression and susceptibility to CTL killing.
  • In vivo studies in TAP-deficient tumor cells and immunodeficient mice.

Main Results:

  • TSA treatment increased the expression of antigen processing machinery components in carcinoma cells.
  • TSA enhanced MHC class I surface expression, leading to increased susceptibility to CTL-mediated killing.
  • TSA suppressed tumor growth in vivo, an effect mediated by increased tumor cell immunogenicity.
  • The anti-tumoral effect of TSA in vivo was dependent on an intact immune system.

Conclusions:

  • HDAC inhibitors like TSA promote anti-tumor immunity through enhanced antigen presentation and MHC class I expression.
  • TSA increases tumor cell immunogenicity, making them more vulnerable to immune surveillance and attack.
  • These findings suggest that HDACi could be valuable in revising cancer immunotherapeutic strategies.

More Related Videos

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells13:18

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...